EquityZen Growth Technology Fund LLC - Series 325
Raised
$1M
Investors
32
Min Invest
$10,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 325 is a Delaware-domiciled pooled investment fund that raised $1.1M from 32 investors under Rule 506(b) and Section 3(c)(1) exemptions, with a $10K minimum investment. This amended filing dated January 2019 is part of the EquityZen platform, which sponsors a large family of pre-IPO investment vehicles through its numbered series structure.
This pre-IPO fund follows a typical platform SPV structure with a moderate minimum investment of $10K, making late-stage private equity accessible to accredited investors. The 506(b) exemption with 3(c)(1) registration relief is standard for pooled pre-IPO vehicles, and the $34K average investor commitment reflects the platform's retail-accessible positioning within the alternative investment category.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Shriram Bhashyam
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
